These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2696699)

  • 1. [Immunoscintigraphy in oncology exemplified by ovarian cancer].
    Pateisky N
    Gynakol Rundsch; 1989; 29 Suppl 3():40-3. PubMed ID: 2696699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [REGAJ diagnosis of recurrence of ovarian cancer].
    Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
    Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic and intraoperative immunoscintigraphy in ovarian cancer.
    Gitsch E; Pateisky N; Schatten C
    Eur J Obstet Gynecol Reprod Biol; 1989 Jul; 32(1):33-7. PubMed ID: 2767320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
    Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
    Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Surwit EA; Childers JM; Krag DN; Katterhagen JG; Gallion HH; Waggoner S; Mann WJ
    Gynecol Oncol; 1993 Mar; 48(3):285-92. PubMed ID: 8462896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in ovarian tumor imaging.
    Fotiou S; Skarlos D; Tserkezoglou A; Aravantinos G; Malamitsi J; Koutoulidis K
    Eur J Gynaecol Oncol; 1988; 9(4):304-7. PubMed ID: 3391206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody imaging of colorectal and ovarian cancer.
    Haseman MK
    West J Med; 1994 Oct; 161(4):412. PubMed ID: 7817555
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125].
    Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL
    Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
    Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
    Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.
    Perkins AC; Pimm MV; Powell MC
    Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunoscintigraphy using monoclonal antibodies before second-look surgery in patients suffering from ovarian cancer.
    Pateisky N; Philipp K; Sevelda P; Skodler WD; Enzelsberger H; Hamilton G; Burchell J; Schatten C
    Gynecol Obstet Invest; 1987; 24(3):211-6. PubMed ID: 3692333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
    Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry.
    Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B
    Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection in patients with suspected ovarian cancer.
    Pateisky N; Philipp K; Skodler WD; Czerwenka K; Hamilton G; Burchell J
    J Nucl Med; 1985 Dec; 26(12):1369-76. PubMed ID: 4067639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoscintigraphy with radionuclide-labeled monoclonal antibodies for tumor diagnosis and in benign diseases].
    Baum RP; Hertel A; Hör G
    Immun Infekt; 1989 Feb; 17(1):22-4. PubMed ID: 2647623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
    Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
    Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
    Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA
    Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radio-immunoscintigraphy and intraoperative tumour detection by means of anti-tumour antibodies in patients with ovarian cancer.
    Gitsch E; Pateisky N
    Baillieres Clin Obstet Gynaecol; 1989 Mar; 3(1):31-6. PubMed ID: 2736839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
    Cannistra SA
    Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoscintigraphy and intraoperative tumor search in ovarian cancer].
    Pateisky N; Gitsch E
    Arch Gynecol Obstet; 1989; 245(1-4):606-9. PubMed ID: 2802745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.